Latest News
Rentokil And Rollins: Revisiting The Quality And Valuation Gap After Earnings
Multinational pest control and hygiene company Rentokil Initial plc reported its H1 2026 results on Thursday, which led to a 20% drop in share price. In this update, I'll review Rentokil's performance
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bloom Energy Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BE
New York, New York--(Newsfile Corp. - August 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Bloom Energy C
Capital Power: Picking Up Stock After A Dividend Hike
Capital Power remains attractive after a Q2 AFFO miss, with management reaffirming 2026 guidance and 2030 targets. CPX's dividend was increased by 2% to C$0.7048 quarterly, yielding 4.3% with a sub-50
FUTU FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Futu Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - FUTU
NEW YORK, Aug. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and Ma
New Crypto Pepeto DeFi Utility Update While Bitcoin Price Prediction Targets $200,000
Dubai, UAE, Aug. 02, 2026 (GLOBE NEWSWIRE) -- Pepeto is engineering a DeFi trading platform built on zero-fee swaps, and the timing has put it at the center of attention, because the boldest Bitcoin p
Is The Next 2008 Coming? Jim Rickards Thinks So. And He Says That's Good News for the Prepared.
Washington, D. C. , Aug. 02, 2026 (GLOBE NEWSWIRE) -- Every crisis has a small group of people who see it coming and come out richer on the other side. Jim Rickards says the AI bubble will be no diffe
SPYI: Stop Looking At The Yield, The Real Opportunity Is Volatility
I rate the NEOS S&P 500 High Income ETF a BUY, as it balances equity exposure with income from market volatility. SPYI's 12% distribution yield is compelling, but its real strength is generating addit
SELLAS Life Sciences: The Ownership Structure Has Changed Before The Defining Catalyst
SELLAS Life Sciences enters its pivotal REGAL readout with a transformed shareholder base, stronger balance sheet, and a new supply structure. Institutional ownership doubled to 36.34%, with average a
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Wix.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WIX
New York, New York--(Newsfile Corp. - August 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Wix.com Ltd. (
How Dynex Capital Transformed Into The Third-Largest Agency mREIT: Yield 15%
The Speedboat Era Ends: Formerly the smallest and most agile agency mREIT, Dynex Capital has systematically expanded its balance sheet to become a dominant player. Portfolio fair value reached $27.6 b
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Wise Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - WSE
New York, New York--(Newsfile Corp. - August 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of W
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit
NEW YORK, Aug. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2
AKRE: A Hold As Performance Surprises On The Upside, Yet Concerns Remain
I maintain the Hold rating on the Akre Focus ETF. AKRE has surprised on the upside since my May article, outperforming the S&P 500 against a rather challenging backdrop, chiefly thanks to its applicat
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
Minjuvi (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy
A Major Breakout In Treasury Yields May Be Underway
Long-dated US Treasury yields have surged as investors demand higher compensation amid reduced Fed forward guidance and increased uncertainty. The term premium remains historically depressed but is ri
This Energy Company Ruined My Saturday Night
I was sitting at Mackenzies Bar & Kitchen on the canal in Bristol, UK, with a friend. Just before 7pm, she got a text from her boyfriend Steve: “the power is flickering here.
After starting the tokenmaxxing panic, Uber's CTO is back with a very different AI story
A version of this story originally appeared in the BI Tech Memo newsletter. Sign up for the weekly BI Tech Memo newsletter here.
Persistent Achieves $452.4M Revenue in Q1 FY27 with 16.1% YoY Growth
/PRNewswire/ -- News Summary Persistent Systems (BSE: 533179) (NSE: PERSISTENT) today announced the Company's audited financial results for the quarter and
AI Can Write Research Papers. But Can Researchers Trust the Citations? Wispaper Says That's the Next Challenge for Academic AI
/PRNewswire/ -- Artificial intelligence has transformed academic writing. Today, researchers can summarize hundreds of papers, generate literature reviews, and
Persistent Achieves $452.4M Revenue in Q1 FY27 with 16.1% YoY Growth
/PRNewswire/ -- News Summary Persistent Systems (BSE: 533179) (NSE: PERSISTENT) today announced the Company's audited financial results for the quarter and